LTR Pharma Ltd (LTP) — Strategic Asset Allocation Index
LTR Pharma Ltd (LTP) has a Strategic Asset Allocation Index of 0.0% as of December 2025. Strategic assets (PP&E of AU$9.87K plus long-term investments of AU$-) total AU$9.87K, measured against net assets of AU$26.86 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check LTR Pharma Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
LTR Pharma Ltd Strategic Asset Allocation Index (2024–2025)
This chart shows how LTR Pharma Ltd's Strategic Asset Allocation Index has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the index stands at 0.0%, representing strategic assets of AU$9.87K against net assets of AU$26.86 Million AUD.
Annual Strategic Asset Allocation Index for LTR Pharma Ltd (2024–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for LTR Pharma Ltd from 2024 to 2025, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see LTP market cap overview.
| Year | SAAI | Strategic Assets (AUD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.4% | AU$136.74K | AU$12.60K | AU$124.14K | AU$31.51 Million | ▲ +0.4 pp |
| 2024 | 0.1% | AU$1.68K | AU$1.68K | AU$- | AU$2.94 Million | — |